Impact Factor
2.08
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.40
3 total citations
h5-index
2
h5 depth signal
Cited share
60.0%
3 of 5
Total citations
3
Citation footprint
Metric signal
0.00
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Citing Geographic Demographics
China
19
Citing Fields of Research
Hematology
2
Lymphomas
2
Immunology
1
Obstetrics/Gynecology
1
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
551
Articles tracked across the journal lifetime
Indexed publication set
5
3 cited publications
Last 12 months
0
0.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
China
19 citing publications
Leading citing field
Hematology
2 citing publications
Latest tracked publication
14 August 2023
10 recent records available
Coverage & Indexing History
v18n1, Jan. 1997-
v18n1, Jan. 1997-
Active Coverage
Active Coverage
Research Focus & Classification
Issuing & Sponsoring Bodies
Contributor
Zhongguo yi xue ke xue yuan
Broad Categories
Hematology
MeSH Descriptors
Hematology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3760/cma.j.issn.0253-2727.2023.08.002
Open DOI
产科弥散性血管内凝血临床诊断与治疗中国专家共识
02
DOI 10.3760/cma.j.issn.0253-2727.2023.08.010
Open DOI
MSN在多发性骨髓瘤中的临床意义及致病机制研究
03
DOI 10.3760/cma.j.issn.0253-2727.2023.07.004
Open DOI
国产苯达莫司汀联合利妥昔单抗一线治疗惰性B细胞淋巴瘤及老年套细胞淋巴瘤的疗效及安全性——多中心、前瞻性、Ⅱ期临床研究
评价国产苯达莫司汀联合利妥昔单抗一线治疗惰性B细胞淋巴瘤（B-iNHL）和老年套细胞淋巴瘤（MCL）的有效性和安全性。 于2020年12月1日至2022年9月10日在山东省内10家三甲医院多中心前瞻性研究国产苯达莫司汀联合利妥昔单抗治疗初诊B-iNHL和老年MCL患者的疗...
04
DOI 10.3760/cma.j.issn.0253-2727.2023.01.007
Open DOI
[Analysis of the effects of low/intermediate dose of coagulation factor Ⅷ on 30 adult patients with severe hemophilia A in a single center].
Objective: To evaluate the clinical effects of low- and intermediate-dose factor Ⅷ (F Ⅷ) prophylaxis in Chinese adult patients with severe hemophilia A. Methods: Thirty adult patients with severe hemophilia A who received low- (n=20) /in...
05
DOI 10.3760/cma.j.issn.0253-2727.2023.01.017
Open DOI
[Allogeneic hematopoietic stem cell transplantation for MDS secondary to Shwachman-Diamond syndrome: a case report].
06
DOI 10.3760/cma.j.issn.0253-2727.2022.04.011
Open DOI
合并轻链型淀粉样变性的初诊多发性骨髓瘤患者临床回顾性分析
分析合并轻链型淀粉样变性（AL）的初诊多发性骨髓瘤（MM）患者的临床特征、疗效及预后。 回顾性分析苏州大学附属第一医院自2017年1月1日至2018年10月31日收治的160例初诊MM患者的临床资料。根据患者骨髓、皮肤和其他部位组织病理活检结果是否合并淀粉样变...
07
DOI 10.3760/cma.j.issn.0253-2727.2022.04.007
Open DOI
LymphGen基因分型在弥漫大B细胞淋巴瘤患者中的分布特征及预后价值验证
了解LymphGen基因分型在弥漫大B细胞淋巴瘤（DLBCL）人群中的分布特征并验证其预后价值。 收集2014年6月至2020年12月在新疆维吾尔自治区人民医院资料完整155例初诊DLBCL患者的临床资料及石蜡包埋肿瘤组织标本，从肿瘤组织中提取DNA，应用二代测序技术检测47...
08
DOI 10.3760/cma.j.issn.0253-2727.2022.03.011
Open DOI
IPSS-R及WPSS移植前评估对异基因造血干细胞移植治疗骨髓增生异常综合征患者预后意义的研究
探究不同时间进行修订版国际预后积分系统（IPSS-R）及WHO预后积分系统（WPSS）评分对异基因造血干细胞移植（allo-HSCT）治疗骨髓增生异常综合征（MDS）患者的预后评估价值。 回顾性分析2016年7月至2019年6月于苏州大学附属第一医院行allo-HSCT的184例MDS患...
09
DOI 10.3760/cma.j.issn.0253-2727.2022.02.002
Open DOI
嵌合抗原受体T细胞治疗相关神经系统毒副反应管理中国专家共识（2022年版）
10
DOI 10.3760/cma.j.issn.0253-2727.2022.02.019
Open DOI
范可尼贫血与DNA链间交联损伤修复的研究进展
Bibliographical & Catalog Notes
Description based on: di 2 juan, di 1 qi, 1981; title from cover.
Also issued online.
Articles in Chinese; table of contents in Chinese and English.